HB1214
Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies, limit.
Status:
In Senate
Latest Action:
Feb. 11, 2026
House: Passed House (98-Y 0-N 0-A)
Chief Patron:
Karrie Delaney (D)
Session:
2026 Regular Session
Summary
As Introduced. Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit.
Decreases the cap on the cost-sharing payment that a covered person is required to pay for a covered prescription insulin drug from $50 to $35 for a 30-day supply of the prescription insulin drug and provides such cap is an aggregate cap that applies in situations where the covered person ... (More) is prescribed more than one insulin drug. The bill also establishes such an aggregate cap of $35 for a 30-day supply of diabetes equipment and supplies. (Less)-
Bill History
- 01/14/2026 - House: Prefiled and ordered printed; Offered 01-14-2026 26101381D
- 01/14/2026 - House: Referred to Committee on Labor and Commerce
- 01/27/2026 - House: Assigned HCL sub: Subcommittee #1
- 01/30/2026 - House: Placed on Labor and Commerce Agenda
- 02/03/2026 - House: Subcommittee recommends reporting (9-Y 0-N)
- 02/04/2026 - House: Placed on Labor and Commerce Agenda
- 02/05/2026 - House: Reported from Labor and Commerce (22-Y 0-N)
- 02/09/2026 - House: Read first time
- 02/10/2026 - House: Read second time and engrossed
- 02/11/2026 - House: Read third time and passed House (96-Y 0-N 0-A)
- 02/11/2026 - House: Reconsideration of passage agreed to by House
- 02/11/2026 - House: Passed House (98-Y 0-N 0-A)
